title: Status and perspectives of neuroprotective therapies in glaucoma: the European Glaucoma Society White Paper.
abstract: Glaucoma, a chronic progressive neuropathy and the most frequent cause of irreversible blindness worldwide, is commonly treated by medication or surgery aimed at lowering intraocular pressure. In view of the limited therapeutic options, the European Glaucoma Society (EGS) sponsored two Think Tank Meetings with the goal of assessing the current status and the overall perspectives for neuroprotective treatment strategies in glaucoma. The results of the meetings are summarized in this EGS White Paper.
authors.affiliation: Institute of Human Anatomy and Embryology, University of Regensburg, Universitätstrasse 31, 93053, Regensburg, Germany. ernst.tamm@vkl.uni-regensburg.de
authors.forename: Ernst R
authors.initials: ER
authors.lastname: Tamm
authors.forename: Leopold
authors.initials: L
authors.lastname: Schmetterer
authors.forename: Franz
authors.initials: F
authors.lastname: Grehn
mesh_terms: D017209:Apoptosis; D015415:Biomarkers / Q000378:metabolism; D003226:Congresses as Topic; D018450:Disease Progression; D005060:Europe; D005901:Glaucoma / Q000175:diagnosis / Q000188:drug therapy* / Q000473:pathology; D006801:Humans; D018696:Neuroprotective Agents / Q000627:therapeutic use*; D055095:Optics and Photonics; D058028:Research Report; D012165:Retinal Ganglion Cells / Q000473:pathology; D012955:Societies, Medical; D033581:Stem Cell Transplantation; D057170:Translational Research, Biomedical
chemical_list: D015415:Biomarkers; D018696:Neuroprotective Agents